Circassia Pharmaceuticals (CSSPF) Price & Analysis

Compare

8 Followers

CSSPF Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.69 - $0.75

Previous CloseN/A

Volume60.00K

Average Volume (3M)100.00

Market Cap

$357.19M

Enterprise Value$235.23M

Total Cash (Recent Filing)£19.90M

Total Debt (Recent Filing)£1.10M

Price to Earnings (P/E)63.3

Beta2.96

Next Earnings

Sep 11, 2025

EPS EstimateN/A

Next Dividend Ex-Date

May 15, 2025

Dividend Yield1.51%

Share Statistics

EPS (TTM)0.01

Shares OutstandingN/A

10 Day Avg. Volume0

30 Day Avg. Volume100

Financial Highlights & Ratios

PEG Ratio2.62

Price to Book (P/B)N/A

Price to Sales (P/S)0.00

Price to Cash Flow (P/CF)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$1.14

Price Target Upside65.75% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering3

---

Circassia Pharmaceuticals News

PremiumCompany Announcements

NIOX Group Announces Final Dividend Timetable for 2024

14d ago

PremiumCompany Announcements

NIOX Group Announces 2025 AGM Details

23d ago

PremiumCompany Announcements

Niox Group PLC Announces Change in Voting Rights

24d ago

PremiumCompany Announcements

NIOX Group’s Director-Related Share Transaction Announced

27d ago

PremiumRatings

Circassia Pharmaceuticals: Buy Rating Reaffirmed Despite Withdrawn Offer, 9.4% Upside Potential

27d ago

PremiumCompany Announcements

NIOX Group Discontinues Private Sale Amid Economic Challenges

27d ago

PremiumCompany Announcements

NIOX Group Seeks Block Admission for Share Trading on AIM

28d ago

PremiumDividends

Circassia Pharmaceuticals (NIOX) Unveils Dividend Details for Q2: Mark Your Calendar!

1M ago

See All CSSPF News

---

Bulls Say, Bears Say

Bulls Say

Acquisition OfferNIOX has announced it has received a possible 81p/share all-cash offer from Keensight Capital valuing the business at £322m.

Financial PerformanceNIOX's fiscal year trading update confirms another solid period of growth, with revenues increasing by 14% to £41.8 million, in line with consensus expectations.

ValuationNIOX trades at a significant discount to peers, with a 2025 estimated price-to-earnings ratio of approximately 13 times, considered too cheap given the company's growth and margin profile.

Bears Say

Macroeconomic EnvironmentKeensight Capital has announced that it does not intend to make a firm offer for the business at this stage due to the current uncertain macroeconomic environment.

Share Price MovementA level of weakness in the share price is anticipated due to recent newsflow and share price action related to it.

---

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

0.87% Insiders

―

Mutual Funds

<0.01% Other Institutional Investors

98.93% Public Companies and

Individual Investors

Detailed Ownership Overview >

CSSPF FAQ

What was Circassia Pharmaceuticals’s price range in the past 12 months?

Circassia Pharmaceuticals lowest stock price was $0.69 and its highest was $0.75 in the past 12 months.

What is Circassia Pharmaceuticals’s market cap?

Circassia Pharmaceuticals’s market cap is $357.19M.

When is Circassia Pharmaceuticals’s upcoming earnings report date?

Circassia Pharmaceuticals’s upcoming earnings report date is Sep 11, 2025 which is in 126 days.

How were Circassia Pharmaceuticals’s earnings last quarter?

Circassia Pharmaceuticals released its earnings results on Apr 01, 2025. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.

Is Circassia Pharmaceuticals overvalued?

According to Wall Street analysts Circassia Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Circassia Pharmaceuticals pay dividends?

Circassia Pharmaceuticals pays a Annually dividend of $0.013 which represents an annual dividend yield of 1.51%. See more information on Circassia Pharmaceuticals dividends here

What is Circassia Pharmaceuticals’s EPS estimate?

Circassia Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Circassia Pharmaceuticals have?

Currently, no data Available

What happened to Circassia Pharmaceuticals’s price movement after its last earnings report?

Circassia Pharmaceuticals reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.758%.

Which hedge fund is a major shareholder of Circassia Pharmaceuticals?

Currently, no hedge funds are holding shares in CSSPF

---

Circassia Pharmaceuticals Stock Smart Score

Neutral

Fundamentals

Return on Equity

4.55%

Trailing 12-Months

Asset Growth

-25.25%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Circassia Pharmaceuticals

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

---

CSSPF Stock 12 Month Forecast

Average Price Target

$1.14

▲(65.75% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","-1":"-$1","1.25":"$1.25","3.5":"$3.5","5.75":"$5.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.2014658,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.1436619454,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.02792074,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.03</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,1.25,3.5,5.75,8],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2018","6":"Sep<br/>2023","9":"Sep<br/>2024","12":"Apr<br/>2025","25":"Apr<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.745,1.703189676923077,1.6613793538461539,1.619569030769231,1.5777587076923079,1.5359483846153847,1.4941380615384616,1.4523277384615385,1.4105174153846154,1.3687070923076923,1.3268967692307694,1.2850864461538463,1.2432761230769231,{"y":1.2014658,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.745,1.6987432265692308,1.6524864531384615,1.6062296797076925,1.5599729062769232,1.513716132846154,1.4674593594153846,1.4212025859846156,1.3749458125538463,1.328689039123077,1.2824322656923077,1.2361754922615384,1.1899187188307692,{"y":1.1436619454,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.745,1.689840056923077,1.634680113846154,1.5795201707692308,1.5243602276923078,1.4692002846153847,1.4140403415384617,1.3588803984615385,1.3037204553846156,1.2485605123076924,1.1934005692307692,1.1382406261538462,1.0830806830769233,{"y":1.02792074,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.44,"date":1522540800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.44,"date":1525132800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.44,"date":1533081600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.44,"date":1535760000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.44,"date":1538352000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.48,"date":1656633600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.48,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.705,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.69,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.705,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.65,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.65,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.745,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >